Home/Filings/4/0000950170-25-073823
4//SEC Filing

Ali Faraz 4

Accession 0000950170-25-073823

CIK 0001858848other

Filed

May 15, 8:00 PM ET

Accepted

May 16, 7:07 PM ET

Size

5.0 KB

Accession

0000950170-25-073823

Insider Transaction Report

Form 4
Period: 2025-05-16
Ali Faraz
DirectorChief Executive Officer
Transactions
  • Sale

    Common Stock

    2025-05-16$0.44/sh3,189$1,412317,325 total
Footnotes (2)
  • [F1]Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 6, 2025.
  • [F2]Includes 259,568 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units.

Documents

1 file

Issuer

Tenaya Therapeutics, Inc.

CIK 0001858848

Entity typeother

Related Parties

1
  • filerCIK 0001667937

Filing Metadata

Form type
4
Filed
May 15, 8:00 PM ET
Accepted
May 16, 7:07 PM ET
Size
5.0 KB